About Semler Scientific, Inc. - Common Stock (SMLR)
Semler Scientific is a healthcare technology company that specializes in developing innovative solutions to enhance the efficiency and accuracy of diagnostic and measurement processes in medical settings. The company focuses on creating proprietary products that allow healthcare providers to assess patients more effectively, particularly in relation to cardiovascular and respiratory health. By leveraging advanced technology and data analytics, Semler aims to improve patient outcomes and streamline interactions between healthcare professionals and patients, ultimately contributing to better overall healthcare delivery. Read More
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. (“Semler” or “the Company”) (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Semler Scientific investors under the federal securities laws.
The financial markets are currently presenting a fascinating dichotomy, with traditional and nascent indicators painting a complex picture of economic sentiment. While equity markets often dominate headlines, the subtle movements in the bond market and the volatile ascent of cryptocurrency are providing crucial insights into broader investor behavior and economic
The financial world is witnessing a seismic shift as institutional investors increasingly embrace digital assets, moving them from the fringes of speculative investment to a core component of diversified portfolios. This accelerating adoption, underscored by recent surveys and the active involvement of financial behemoths, signals a profound transformation in how
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), or Cleveland-Cliffs (CLF) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), Adtran (ADTN), or Fulgent (FLGT) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In SelectQuote (SLQT), Cleveland-Cliffs (CLF), EchoStar (SATS), or Semler (SMLR) To Contact Him Directly To Discuss Their Options
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
